Pro-opiomelanocortin in human pregnancy: evolution of maternal plasma levels, concentrations in cord blood, amniotic fluid and at the feto-maternal interface

Citation
Ml. Raffin-sanson et al., Pro-opiomelanocortin in human pregnancy: evolution of maternal plasma levels, concentrations in cord blood, amniotic fluid and at the feto-maternal interface, EUR J ENDOC, 142(1), 2000, pp. 53-59
Citations number
36
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
EUROPEAN JOURNAL OF ENDOCRINOLOGY
ISSN journal
08044643 → ACNP
Volume
142
Issue
1
Year of publication
2000
Pages
53 - 59
Database
ISI
SICI code
0804-4643(200001)142:1<53:PIHPEO>2.0.ZU;2-T
Abstract
Objective: The human placenta normally expresses the pro-opiomelanocortin ( POMC) gene. The pattern and secretory kinetics of POMC and/or POMC-derived peptides by the placenta during gestation is still debated. We recently dem onstrated that full length POMC was a normal product of the human placenta, The aim of our study was to establish its normal secretory kinetics and to explore its physiological relevance, Design: In a prospective, longitudinal study, thirty normal pregnant women had monthly measurements of plasma POMC, In a cross-sectional study of 128 healthy pregnant women, plasma POMC and human chorionic gonadotrophin (hCG) were concomitantly measured to assess their correlation. Finally, POMC lev els were assessed in venous and arterial cord blood samples, in amniotic fl uid and in retroplacental blood. Methods: Plasma POMC was measured by a specific IRMA in unextracted blood o r biological fluid. Results: Plasma POMC became detectable by the 8th week of pregnancy and rea ched its maximum at around the 20th week, remaining stable thereafter. The relationship between POMC and gestation time (weeks) best fitted with a thi rd degree polynomia curve, A significant negative correlation (P = 0.01) wa s observed between plasma levels of POMC and hCG after adjustment for gesta tion time to take into account the dependence of both hormones on this para meter. POMC was not secreted into the fetal circulation at term, but was pr esent in very high levels in amniotic fluid. The highest levels of POMC wer e present in the retroplacental blood where the values were 35 times higher than in maternal blood; by comparison, corticotrophin releasing hormone an d ACTH values in this compartment were twice or equal to those in the mater nal blood. Conclusion: Placental POMC secretion increases during the first half of pre gnancy and reaches a plateau from the 20th week to delivery. The inverse co rrelation between POMC and hCG plasma levels, and very high POMC levels at the fete-maternal interface suggest a physiological role for this precursor during pregnancy.